New sepsis biomarkers
Sepsis remains a leading cause of death in the intensive care units and in all age groups worldwide. Early recognition and diagnosis are key to achieving improved outcomes. Therefore, novel biomarkers that might better inform clinicians treating such patients are surely needed. The main attributes o...
Main Authors: | Dolores Limongi, Cartesio D'Agostini, Marco Ciotti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-06-01
|
Series: | Asian Pacific Journal of Tropical Biomedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2221169116302933 |
Similar Items
-
Current Evidence and Limitation of Biomarkers for Detecting Sepsis and Systemic Infection
by: Shang-Kai Hung, et al.
Published: (2020-11-01) -
Presepsin as a sepsis biomarker
by: K. A. Trunova
Published: (2018-05-01) -
Presepsin level in predicting patients’ in-hospital mortality from sepsis under sepsis-3 criteria
by: Wen MY, et al.
Published: (2019-06-01) -
Presepsin: A promising biomarker for the detection of bacterial infections
by: Mohammad Yousef Memar, et al.
Published: (2019-03-01) -
Academy of Emergency Medicine and Care-Society of Clinical Biochemistry and Clinical Molecular Biology consensus recommendations for clinical use of sepsis biomarkers in the emergency department
by: Giuseppe Lippi, et al.
Published: (2017-11-01)